Sandoz Group AG (OTCMKTS:SDZNY) Short Interest Update

Sandoz Group AG (OTCMKTS:SDZNY) was the recipient of a significant decrease in short interest during the month of February. As of February 28th, there was short interest totalling 54,700 shares, a decrease of 85.1% from the February 13th total of 366,500 shares. Currently, 0.0% of the company’s stock are short sold. Based on an average daily volume of 53,600 shares, the days-to-cover ratio is presently 1.0 days.

Sandoz Group Trading Up 3.3 %

SDZNY stock traded up $1.36 during trading on Wednesday, reaching $42.18. The stock had a trading volume of 32,202 shares, compared to its average volume of 41,895. Sandoz Group has a one year low of $27.79 and a one year high of $49.81. The company’s 50 day moving average is $45.35 and its two-hundred day moving average is $43.95.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on SDZNY. UBS Group cut Sandoz Group from a “strong-buy” rating to a “hold” rating in a research report on Monday, February 3rd. BNP Paribas downgraded shares of Sandoz Group from a “strong-buy” rating to a “hold” rating in a report on Monday, December 2nd.

Sandoz Group Company Profile

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.